VERA أخبار الفوركس
Vera Therapeutics Says FDA Grants Breakthrough Therapy Designation For Atacicept To Treat IgAN
Biotechnology company Vera Therapeutics, Inc. (VERA) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to atacicept for the treatment of Immunoglobulin A Nephropathy or IgAN.
RTTNews
|
862 منذ أيام
